ACS-SU2C Announce First Collaborative Grant Focused on Lung Cancer

The American Cancer Society (ACS) and Stand Up To Cancer (SU2C) have recently teamed up in an effort to fight cancer in the United States. The two organizations announced their first collaboration is a $20 million research initiative called the “Dream Team” focused on developing new therapies for lung cancer.

Many have regarded the alliance between the two organizations as historic in the field of lung cancer research.

Otis W. Brawley, M.D., F.A.C.P., chief medical officer for the American Cancer Society said, “By combining forces with SU2C, the Society looks forward to leveraging our combined resources with the extraordinary collaboration made possible by the Dream Team research model to transform the field of lung cancer research.”

Lung cancer is the leading cause of cancer death for both men and women. It is estimated that 9,100 Illinois residents will be diagnosed with lung and bronchial cancer this year, according to the American Cancer Society’s 2014 Facts and Figures Report.

You can read more about the ACS-SU2C collaboration here.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.